Cargando…
Subcutaneous Infection Model Facilitates Treatment Assessment of Secondary Alveolar Echinococcosis in Mice
Alveolar echinococcosis (AE) in humans is a parasitic disease characterized by severe damage to the liver and occasionally other organs. AE is caused by infection with the metacestode (larval) stage of the fox tapeworm Echinococcus multilocularis, usually infecting small rodents as natural intermedi...
Autores principales: | Küster, Tatiana, Hermann, Corina, Hemphill, Andrew, Gottstein, Bruno, Spiliotis, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662659/ https://www.ncbi.nlm.nih.gov/pubmed/23717701 http://dx.doi.org/10.1371/journal.pntd.0002235 |
Ejemplares similares
-
Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen
por: Boubaker, Ghalia, et al.
Publicado: (2015) -
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis
por: Stadelmann, Britta, et al.
Publicado: (2016) -
Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014) -
Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice
por: Gómez, Cristina, et al.
Publicado: (2021) -
Echinococcus P29 Antigen: Molecular Characterization and Implication on Post-Surgery Follow-Up of CE Patients Infected with Different Species of the Echinococcus granulosus Complex
por: Boubaker, Ghalia, et al.
Publicado: (2014)